tm logo
SYNAPTAN
Dead/Cancelled
IR CANCELLED; US REGISTRATION CANCELLED

on 27 Oct 2016

Last Applicant/ Owned by

F-92100 BOULOGNE BILLANCOURT

Serial Number

79032294 filed on 27th Oct 2006

Registration Number

3423093 registered on 06th May 2008

in the Principal Register

Correspondent Address

F-92100 BOULOGNE BILLANCOURT, France

Filing Basis

No Filing Basis

Disclaimer

NO DATA

SYNAPTAN

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases, laxatives and purgative agents; pharmaceutical preparations for in use in the treatment of cardiovascular diseases, circulatory disorders, cancer, neurological diseases, orthopedic disorders, urological diseases, hormonal disorders; pharmaceutical preparations for use in the trea Read More

Classification Information


Class [003]
Cosmetics and Cleaning Products


Perfumery, essential oils, cosmetics, hair lotions

Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases, laxatives and purgative agents; pharmaceutical preparations for in use in the treatment of cardiovascular diseases, circulatory disorders, cancer, neurological diseases, orthopedic disorders, urological diseases, hormonal disorders; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for the treatment of diabetes and diabetes-related disorders; pharmaceutical preparations for the treatment of ophthalmological disorders; pharmaceutical preparations for the treatment of age-related disorders; pharmaceutical preparations for the treatment of cough; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for cosmetic purposes for the treatment of frown lines and other facial wrinkles, human skin and of imbalances and defects therein; pharmaceutical preparations for use in cosmetic surgery; pharmaceutical preparations for the treatment of pain, muscle spasm, hemifacial spasm, blepharospasm, dystonia, torticollis, cerebral palsy, articular pathologies, acne, headache, migraine, hyperhydrosis, myofascial pain, and hyperfunctional facial lines; pharmaceutical preparations for the treatment of frown lines and other facial wrinkles, human skin and of imbalances and defects therein; pharmaceutical preparations for the treatment of dermatological disorders namely scars and psoriasis ; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for the treatment of frown lines and other facial wrinkles, human skin and of imbalances and defects therein; Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases, laxatives and purgative agents; veterinary preparations for use in the treatment of cardiovascular diseases and circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of hormonal disorders; veterinary preparations for use in the treatment of blood diseases; veterinary preparations for use in the treatment of muscle disorders, all for use in domestic or farm animals

Mark Details


Serial Number

No 79032294

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Sep 2017UNDELIVERABLE MAIL - NO ACTION TAKEN
26th May 2017DEATH OF INTERNATIONAL REGISTRATION
26th May 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
24th Sep 2015TOTAL INVALIDATION PROCESSED BY THE IB
02th Sep 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02th Sep 2015INVALIDATION PROCESSED
12th Aug 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12th Dec 2014CANCELLED SECTION 71
13th May 2013FINAL DECISION TRANSACTION PROCESSED BY IB
12th Nov 2009NEW REPRESENTATIVE AT IB RECEIVED